# Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty

> **NCT04885816** · NA · TERMINATED · sponsor: **Instituto Nacional de Cardiologia Ignacio Chavez** · enrollment: 5 (actual)

## Conditions studied

- High Bleeding Risk
- Coronary Artery Disease (CAD)
- Percutaneous Coronary Intervention (PCI)

## Interventions

- **DEVICE:** Drug Eluting Balloon (DEB)
- **DEVICE:** Drug Eluting Stents (DES)

## Key facts

- **NCT ID:** NCT04885816
- **Lead sponsor:** Instituto Nacional de Cardiologia Ignacio Chavez
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-20
- **Primary completion:** 2021-09-29
- **Final completion:** 2021-09-29
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Slow recruitment
- **Last updated:** 2021-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04885816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04885816, "Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04885816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*